POLYRIZON LTD (PLRZ) Stock Price, Forecast & Analysis

NASDAQ:PLRZ • IL0011814113

12.49 USD
-1.2 (-8.77%)
Last: Feb 27, 2026, 05:06 PM

PLRZ Key Statistics, Chart & Performance

Key Statistics
Market Cap19.86M
Revenue(TTM)N/A
Net Income(TTM)-1.78M
Shares1.59M
Float1.28M
52 Week High2235
52 Week Low2.88
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)-807.27
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2024-10-29
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
PLRZ short term performance overview.The bars show the price performance of PLRZ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 100 200 300

PLRZ long term performance overview.The bars show the price performance of PLRZ in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PLRZ is 12.49 USD. In the past month the price increased by 1.52%. In the past year, price decreased by -98.83%.

POLYRIZON LTD / PLRZ Daily stock chart

PLRZ Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to PLRZ. When comparing the yearly performance of all stocks, PLRZ is one of the better performing stocks in the market, outperforming 96.64% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
PLRZ Full Technical Analysis Report

PLRZ Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to PLRZ. PLRZ has a great financial health rating, but its profitability evaluates not so good.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
PLRZ Full Fundamental Analysis Report

PLRZ Financial Highlights

Over the last trailing twelve months PLRZ reported a non-GAAP Earnings per Share(EPS) of -807.27. The EPS decreased by -207.27% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -9.51%
ROE -9.7%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%99.67%
Sales Q2Q%N/A
EPS 1Y (TTM)-207.27%
Revenue 1Y (TTM)N/A
PLRZ financials

PLRZ Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
PLRZ Analyst EstimatesPLRZ Analyst Ratings

PLRZ Ownership

Ownership
Inst Owners0.13%
Ins Owners10%
Short Float %4.01%
Short Ratio0.06
PLRZ Ownership

PLRZ Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC15.98397.113B
AMGN AMGEN INC17.23204.262B
GILD GILEAD SCIENCES INC16.7178.373B
VRTX VERTEX PHARMACEUTICALS INC24.37121.819B
REGN REGENERON PHARMACEUTICALS16.8381.488B
ALNY ALNYLAM PHARMACEUTICALS INC49.743.76B
INSM INSMED INC N/A31.99B
NTRA NATERA INC N/A30.068B
BIIB BIOGEN INC12.6127.594B
UTHR UNITED THERAPEUTICS CORP17.121.685B

About PLRZ

Company Profile

PLRZ logo image Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..

Company Info

POLYRIZON LTD

HaTidhar St. 5

Ra'anana IL

Employees: 1

PLRZ Company Website

PLRZ Investor Relations

Phone: 97293740120

POLYRIZON LTD / PLRZ FAQ

Can you describe the business of POLYRIZON LTD?

Polyrizon Ltd. is a development stage biotech company, which engages in the development of nasal hydrogels. The firm is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The firm is focused not only on the development of intranasal products, but also on commercialization. The firm cooperates with medical specialists and researchers..


What is the current price of PLRZ stock?

The current stock price of PLRZ is 12.49 USD. The price decreased by -8.77% in the last trading session.


What is the dividend status of POLYRIZON LTD?

PLRZ does not pay a dividend.


How is the ChartMill rating for POLYRIZON LTD?

PLRZ has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for PLRZ stock?

POLYRIZON LTD (PLRZ) does not have a PE ratio as the earnings reported over the last twelve months were negative (-807.27).


What is the ownership structure of POLYRIZON LTD (PLRZ)?

You can find the ownership structure of POLYRIZON LTD (PLRZ) on the Ownership tab.